Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia E Maxson

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Acta Histochemica|February 4, 2010
The cell giveth and the cell taketh away: an overview of Notch pathway activation by endocytic trafficking of ligands and receptorsEmily B Pratt, Jill S Wentzell, Julia E Maxson, et al.
The Journal of Biological Chemistry|March 25, 2018
Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activationHaijiao Zhang, Cody Coblentz, Kevin Watanabe-Smith, et al.
The Journal of Biological Chemistry|January 10, 2014
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerizationJulia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
Journal of Neuroinflammation|October 4, 2012
Expression of myeloid differentiation factor 88 in neurons is not requisite for the induction of sickness behavior by interleukin-1βTheodore P Braun, Aaron J Grossberg, Biliana O Veleva-Rotse, et al.
Leukemia Research Reports|September 3, 2014
Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemiaKim-Hien T Dao, Magdolna B Solti, Julia E Maxson, et al.
Leukemia|July 6, 2022
Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemiaSarah A Carratt, Theodore P Braun, Cody Coblentz, et al.
Leukemia|May 18, 2021
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemiaSarah A Carratt, Theodore P Braun, Cody Coblentz, et al.
Blood|March 19, 2020
Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemiaKatherine Tarlock, Todd Alonzo, Yi-Cheng Wang, et al.
Genome Biology|July 5, 2022
GoPeaks: histone modification peak calling for CUT&TagWilliam M Yashar, Garth Kong, Jake VanCampen, et al.
The Journal of Biological Chemistry|April 28, 2023
Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activityMichael J Hollander, Stacy A Malaker, Nicholas M Riley, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Acta Histochemica|February 4, 2010
The cell giveth and the cell taketh away: an overview of Notch pathway activation by endocytic trafficking of ligands and receptorsEmily B Pratt, Jill S Wentzell, Julia E Maxson, et al.
The Journal of Biological Chemistry|March 25, 2018
Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activationHaijiao Zhang, Cody Coblentz, Kevin Watanabe-Smith, et al.
The Journal of Biological Chemistry|January 10, 2014
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerizationJulia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
Journal of Neuroinflammation|October 4, 2012
Expression of myeloid differentiation factor 88 in neurons is not requisite for the induction of sickness behavior by interleukin-1βTheodore P Braun, Aaron J Grossberg, Biliana O Veleva-Rotse, et al.
Leukemia Research Reports|September 3, 2014
Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemiaKim-Hien T Dao, Magdolna B Solti, Julia E Maxson, et al.
Leukemia|July 6, 2022
Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemiaSarah A Carratt, Theodore P Braun, Cody Coblentz, et al.
Leukemia|May 18, 2021
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemiaSarah A Carratt, Theodore P Braun, Cody Coblentz, et al.
Blood|March 19, 2020
Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemiaKatherine Tarlock, Todd Alonzo, Yi-Cheng Wang, et al.
Genome Biology|July 5, 2022
GoPeaks: histone modification peak calling for CUT&TagWilliam M Yashar, Garth Kong, Jake VanCampen, et al.
The Journal of Biological Chemistry|April 28, 2023
Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activityMichael J Hollander, Stacy A Malaker, Nicholas M Riley, et al.
Pageof 5